$NREF
NexPoint Real Estate Finance, Inc.

2023 Q2 Form 10-Q Financial Statement

#000178624823000009 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $26.66M $27.08M
YoY Change 25.86% -13.6%
Cost Of Revenue $14.16M $13.26M
YoY Change 38.97% 33.1%
Gross Profit $12.51M $13.82M
YoY Change 13.72% -35.35%
Gross Profit Margin 46.9% 51.05%
Selling, General & Admin $4.035M $4.477M
YoY Change 52.38% 79.73%
% of Gross Profit 32.26% 32.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $478.0K $476.0K
YoY Change -49.47% -49.58%
% of Gross Profit 3.82% 3.44%
Operating Expenses $5.098M $4.443M
YoY Change 36.75% 22.33%
Operating Profit $7.408M $9.378M
YoY Change 1.91% -47.16%
Interest Expense $13.09M $12.21M
YoY Change 43.78% 38.49%
% of Operating Profit 176.75% 130.22%
Other Income/Expense, Net $9.370M $10.95M
YoY Change 155.52% -1493.0%
Pretax Income $8.477M $9.378M
YoY Change 0.28% -49.95%
Income Tax
% Of Pretax Income
Net Earnings $8.477M $9.378M
YoY Change 0.28% -49.95%
Net Earnings / Revenue 31.79% 34.64%
Basic Earnings Per Share $0.33 $0.38
Diluted Earnings Per Share $0.33 $0.37
COMMON SHARES
Basic Shares Outstanding 17.18M shares 17.47M shares
Diluted Shares Outstanding 23.08M shares 22.68M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.66M $38.83M
YoY Change -62.69% 10.18%
Cash & Equivalents $19.66M $38.83M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $19.66M $38.83M
YoY Change -62.69% 10.18%
LONG-TERM ASSETS
Property, Plant & Equipment $58.61M $59.07M
YoY Change -3.0% -3.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $111.0K $1.000M
YoY Change -100.0% -99.99%
Other Assets $1.922M $1.495M
YoY Change 52.42% 730.56%
Total Long-Term Assets $7.584B $8.004B
YoY Change -2.88% 0.22%
TOTAL ASSETS
Total Short-Term Assets $19.66M $38.83M
Total Long-Term Assets $7.584B $8.004B
Total Assets $7.603B $8.043B
YoY Change -3.28% 0.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.352M $5.377M
YoY Change 0.94% -17.17%
Accrued Expenses $6.385M $10.19M
YoY Change 42.11% 32.39%
Deferred Revenue
YoY Change
Short-Term Debt $333.2M $350.4M
YoY Change 6.68% 17.98%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $348.0M $366.0M
YoY Change 6.39% 17.61%
LONG-TERM LIABILITIES
Long-Term Debt $6.789B $7.204B
YoY Change -3.28% 0.03%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $6.789B $7.204B
YoY Change -3.28% 0.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $348.0M $366.0M
Total Long-Term Liabilities $6.789B $7.204B
Total Liabilities $7.137B $7.570B
YoY Change -2.85% 0.76%
SHAREHOLDERS EQUITY
Retained Earnings -$9.313M -$2.697M
YoY Change -130.02% -107.99%
Common Stock $393.4M $392.4M
YoY Change 13.08% 16.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $371.5M $377.2M
YoY Change
Total Liabilities & Shareholders Equity $7.603B $8.043B
YoY Change -3.28% 0.26%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $8.477M $9.378M
YoY Change 0.28% -49.95%
Depreciation, Depletion And Amortization $478.0K $476.0K
YoY Change -49.47% -49.58%
Cash From Operating Activities $7.525M $14.95M
YoY Change -41.52% -61.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $364.6M $66.73M
YoY Change -26.81% -68.39%
Cash From Investing Activities $364.6M $66.73M
YoY Change -26.81% -68.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -390.9M -$61.70M
YoY Change -20.63% -75.06%
NET CHANGE
Cash From Operating Activities 7.525M $14.95M
Cash From Investing Activities 364.6M $66.73M
Cash From Financing Activities -390.9M -$61.70M
Net Change In Cash -18.75M $19.98M
YoY Change -201.22% 811.82%
FREE CASH FLOW
Cash From Operating Activities $7.525M $14.95M
Capital Expenditures $0.00 $0.00
Free Cash Flow $7.525M $14.95M
YoY Change -41.52% -110.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
900000 usd
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
200000 usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001786248
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39210
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
NexPoint Real Estate Finance, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2178264
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Crescent Court, Suite 700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2022Q4 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 usd
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2023Q1 dei City Area Code
CityAreaCode
214
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
276-6300
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17184231 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38830000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20048000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
1495000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
299000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
59072000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
245222000 usd
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
284548000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
256147000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
76998000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
78264000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
723343000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
726531000 usd
CY2023Q1 us-gaap Nontrade Receivables
NontradeReceivables
17467000 usd
CY2022Q4 us-gaap Nontrade Receivables
NontradeReceivables
15665000 usd
CY2023Q1 nref Accounts Receivable And Other Assets
AccountsReceivableAndOtherAssets
1106000 usd
CY2022Q4 nref Accounts Receivable And Other Assets
AccountsReceivableAndOtherAssets
2197000 usd
CY2023Q1 us-gaap Assets
Assets
8042566000 usd
CY2022Q4 us-gaap Assets
Assets
8154136000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
687480000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
687885000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
331020000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
205176000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
204960000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
32235000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
121236000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
5377000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6231000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10189000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7986000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
7569590000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7609122000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
95712000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
96501000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2023Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 usd
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-34000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17471218 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17366930 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17184231 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17079943 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
172000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
171000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
392440000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
392124000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2697000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4435000 usd
CY2023Q1 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000 shares
CY2022Q4 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000 shares
CY2023Q1 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
377264000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448513000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8042566000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8154136000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
16161000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
31133000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
12212000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
8818000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3949000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
22315000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1267000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
329000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
151000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
317000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
173000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
1490000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 usd
CY2023Q1 nref Income From Real Estate Investment Partnership
IncomeFromRealEstateInvestmentPartnership
1028000 usd
CY2022Q1 nref Income From Real Estate Investment Partnership
IncomeFromRealEstateInvestmentPartnership
2387000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10949000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1814000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2152000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1763000 usd
CY2023Q1 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
1043000 usd
CY2022Q1 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
1141000 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
828000 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
728000 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1497000 usd
CY2022Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2428000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9378000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
18069000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
874000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
874000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1937000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4783000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6567000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12406000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17118000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13855000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22678000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22030000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
7175000 usd
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.6850
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448513000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
317000 usd
CY2023Q1 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
64434000 usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-874000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6567000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5313
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
874000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.6850
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
12075000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
377264000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245283000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
533000 usd
CY2022Q1 nref Conversion Of Redeemable Noncontrolling Interests In The Op
ConversionOfRedeemableNoncontrollingInterestsInTheOP
113535000 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-874000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12406000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5313
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
874000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5000
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
7521000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
358873000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9378000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
18069000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3531000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9900000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3500000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3030000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
476000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
944000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
11000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-34000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
151000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2564000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8545000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
1490000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
847000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
673000 usd
CY2023Q1 nref Payment In Kind
PaymentInKind
209000 usd
CY2022Q1 nref Payment In Kind
PaymentInKind
168000 usd
CY2023Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-247000 usd
CY2022Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
1912000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-292000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1317000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3290000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3711000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-453000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2138000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14950000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37716000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
36743000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
124633000 usd
CY2023Q1 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
0 usd
CY2022Q1 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
13433000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
28816000 usd
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
52862000 usd
CY2023Q1 nref Payments For Purchase Of Common Stock
PaymentsForPurchaseOfCommonStock
1000000 usd
CY2022Q1 nref Payments For Purchase Of Common Stock
PaymentsForPurchaseOfCommonStock
0 usd
CY2023Q1 nref Payments For Adjustment On Deconsolidation Of Real Estate
PaymentsForAdjustmentOnDeconsolidationOfRealEstate
4992000 usd
CY2022Q1 nref Payments For Adjustment On Deconsolidation Of Real Estate
PaymentsForAdjustmentOnDeconsolidationOfRealEstate
0 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
184552000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
58000 usd
CY2022Q1 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
21000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
66732000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
73399000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
405000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
86410000 usd
CY2023Q1 nref Borrowings Under Master Repurchase Agreements
BorrowingsUnderMasterRepurchaseAgreements
26801000 usd
CY2022Q1 nref Borrowings Under Master Repurchase Agreements
BorrowingsUnderMasterRepurchaseAgreements
25141000 usd
CY2023Q1 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
7422000 usd
CY2022Q1 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
14474000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
89634000 usd
CY2023Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
0 usd
CY2022Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
34173000 usd
CY2023Q1 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
0 usd
CY2022Q1 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
55000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
113535000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
113535000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
530000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
140000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11771000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7197000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
874000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
874000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3023000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3569000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
655000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-61704000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-102136000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19978000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8979000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20347000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33232000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40325000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42211000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
9793000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4910000 usd
CY2023Q1 nref Accounts And Financing Receivable After Allowance For Credit Loss Valuation Adjustment Due To Deconsolidation Of Real Estate
AccountsAndFinancingReceivableAfterAllowanceForCreditLossValuationAdjustmentDueToDeconsolidationOfRealEstate
36022000 usd
CY2022Q1 nref Accounts And Financing Receivable After Allowance For Credit Loss Valuation Adjustment Due To Deconsolidation Of Real Estate
AccountsAndFinancingReceivableAfterAllowanceForCreditLossValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Real Estate Investment Property Net Valuation Adjustment Due To Deconsolidation Of Real Estate
RealEstateInvestmentPropertyNetValuationAdjustmentDueToDeconsolidationOfRealEstate
185732000 usd
CY2022Q1 nref Real Estate Investment Property Net Valuation Adjustment Due To Deconsolidation Of Real Estate
RealEstateInvestmentPropertyNetValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Nontrade Receivables Valuation Adjustment Due To Deconsolidation Of Real Estate
NontradeReceivablesValuationAdjustmentDueToDeconsolidationOfRealEstate
2049000 usd
CY2022Q1 nref Nontrade Receivables Valuation Adjustment Due To Deconsolidation Of Real Estate
NontradeReceivablesValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Accounts Receivable And Other Assets Valuation Adjustment Due To Deconsolidation Of Real Estate
AccountsReceivableAndOtherAssetsValuationAdjustmentDueToDeconsolidationOfRealEstate
799000 usd
CY2022Q1 nref Accounts Receivable And Other Assets Valuation Adjustment Due To Deconsolidation Of Real Estate
AccountsReceivableAndOtherAssetsValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Secured Debt Valuation Adjustment Due To Deconsolidation Of Real Estate
SecuredDebtValuationAdjustmentDueToDeconsolidationOfRealEstate
89012000 usd
CY2022Q1 nref Secured Debt Valuation Adjustment Due To Deconsolidation Of Real Estate
SecuredDebtValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Interest Payable Valuation Adjustment Due To Deconsolidation Of Real Estate
InterestPayableValuationAdjustmentDueToDeconsolidationOfRealEstate
1087000 usd
CY2022Q1 nref Interest Payable Valuation Adjustment Due To Deconsolidation Of Real Estate
InterestPayableValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Stockholders Equity Attributable To Noncontrolling Interest Valuation Adjustment Due To Deconsolidation Of Real Estate
StockholdersEquityAttributableToNoncontrollingInterestValuationAdjustmentDueToDeconsolidationOfRealEstate
64434000 usd
CY2022Q1 nref Stockholders Equity Attributable To Noncontrolling Interest Valuation Adjustment Due To Deconsolidation Of Real Estate
StockholdersEquityAttributableToNoncontrollingInterestValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Retained Earnings Accumulated Deficit Valuation Adjustment Due To Deconsolidation Of Real Estate
RetainedEarningsAccumulatedDeficitValuationAdjustmentDueToDeconsolidationOfRealEstate
1490000 usd
CY2022Q1 nref Retained Earnings Accumulated Deficit Valuation Adjustment Due To Deconsolidation Of Real Estate
RetainedEarningsAccumulatedDeficitValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Redeemable Noncontrolling Interest Equity Carrying Amount Valuation Adjustment Due To Deconsolidation Of Real Estate
RedeemableNoncontrollingInterestEquityCarryingAmountValuationAdjustmentDueToDeconsolidationOfRealEstate
297000 usd
CY2022Q1 nref Redeemable Noncontrolling Interest Equity Carrying Amount Valuation Adjustment Due To Deconsolidation Of Real Estate
RedeemableNoncontrollingInterestEquityCarryingAmountValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 nref Increase In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits
304000 usd
CY2022Q1 nref Increase In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits
324000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates and Assumptions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that these estimates could change in the near term. Estimates are inherently subjective in nature and actual results could differ from our estimates and the differences could be material.</span></div>
CY2023Q1 nref Number Of Classes Of Stock
NumberOfClassesOfStock
3 class
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
700000 usd
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2300000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-34000.000 usd
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2300000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q1 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
971018000 usd
CY2023Q1 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1007891000 usd
CY2023Q1 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
50 loan
CY2023Q1 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9088
CY2023Q1 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0644
CY2023Q1 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P4Y11M26D
CY2022Q4 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
942449000 usd
CY2022Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
982678000 usd
CY2022Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
48 loan
CY2022Q4 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9064
CY2022Q4 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0643
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P5Y1M9D
CY2023Q1 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
55000000.0 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
40900000 usd
CY2023Q1 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
50 loan
CY2023Q1 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1007891000 usd
CY2023Q1 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
48 loan
CY2022Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
982678000 usd
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2023Q1 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
50 loan
CY2023Q1 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2023Q1 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1267000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
329000 usd
CY2023Q1 nref Interest Income And Gains Loss On Debt Securities Trading
InterestIncomeAndGainsLossOnDebtSecuritiesTrading
-939000 usd
CY2022Q1 nref Interest Income And Gains Loss On Debt Securities Trading
InterestIncomeAndGainsLossOnDebtSecuritiesTrading
-3175000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2416000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
59072000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1940000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
245222000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
355148000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5486000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
82594000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
206764000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6500000 usd
CY2023Q1 nref Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
621867000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1278359000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17471218 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17184231 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 usd
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
327422 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4800000 usd
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.61
CY2021Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
40435 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
286987 shares
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13758905.9 shares
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132 shares
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774570 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033 shares
CY2022Q4 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
2100000 shares
CY2022Q4 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
2100000 shares
CY2023Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
8748735 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2023Q1 nref Common Stock Special Dividends Per Share Declared
CommonStockSpecialDividendsPerShareDeclared
0.185
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6567000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12406000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1937000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4783000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8504000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
17189000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17118000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13855000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
522000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
525000 shares
CY2023Q1 nref Average Number Of Op Units And Sub Op Units
AverageNumberOfOPUnitsAndSubOPUnits
5038000 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774570 shares
CY2022Q1 nref Average Number Of Op Units And Sub Op Units
AverageNumberOfOPUnitsAndSubOPUnits
7650000 shares
CY2023Q1 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
22678000 shares
CY2022Q1 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
22030000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
96501000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 usd
CY2023Q1 nref Redeemable Noncontrolling Interest Equity Carrying Amount Valuation Adjustment Due To Deconsolidation Of Real Estate
RedeemableNoncontrollingInterestEquityCarryingAmountValuationAdjustmentDueToDeconsolidationOfRealEstate
297000 usd
CY2022Q1 nref Redeemable Noncontrolling Interest Equity Carrying Amount Valuation Adjustment Due To Deconsolidation Of Real Estate
RedeemableNoncontrollingInterestEquityCarryingAmountValuationAdjustmentDueToDeconsolidationOfRealEstate
0 usd
CY2023Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1937000 usd
CY2022Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
4943000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 usd
CY2022Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
113535000 usd
CY2023Q1 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
3023000 usd
CY2022Q1 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
3569000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
95712000 usd
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
149262000 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17184231 shares
CY2023Q1 nref Common Stock And Partner Units Shares Outstanding
CommonStockAndPartnerUnitsSharesOutstanding
22222613 shares
CY2023Q1 us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
CY2021Q3 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13758905.9 shares
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132 shares
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033 shares
CY2022Q4 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
2100000 shares
CY2022Q4 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
2100000 shares
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
800000 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
700000 usd
CY2022Q1 nref Number Of Units
NumberOfUnits
368 unit
CY2023Q1 nref Common Equity Interests Transferred
CommonEquityInterestsTransferred
54000 usd
CY2023Q1 nref Preferred Equity Method Investment Guaranteed Payment
PreferredEquityMethodInvestmentGuaranteedPayment
115300000 usd
CY2022Q3 nref Preferred Equity Method Investments
PreferredEquityMethodInvestments
65300000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
1500000 usd
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount
PurchaseOfPreferredEquityPurchaseAmount
50000000 usd
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
25000000 usd
CY2021Q3 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3000000 usd
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
30000000 usd
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3800000 usd
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
18500000 usd
CY2022Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
15000000 usd
CY2023Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
1000000 usd
CY2023Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
1700000 usd
CY2023Q1 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
30900000 usd
CY2023Q1 nref Preferred Units Extension Term
PreferredUnitsExtensionTerm
P2Y
CY2021Q3 nref Preferred Units Distribution Rate
PreferredUnitsDistributionRate
100.0
CY2023Q1 nref Preferred Equity Method Investments
PreferredEquityMethodInvestments
24000000 usd
CY2023Q1 nref Multiple On Invested Capital
MultipleOnInvestedCapital
1.30
CY2023Q1 nref Preferred Equity Investment Placement Fee
PreferredEquityInvestmentPlacementFee
0.010

Files In Submission

Name View Source Status
nref-20230331_cal.xml Edgar Link unprocessable
nref-20230331_lab.xml Edgar Link unprocessable
0001786248-23-000009-index-headers.html Edgar Link pending
0001786248-23-000009-index.html Edgar Link pending
0001786248-23-000009.txt Edgar Link pending
0001786248-23-000009-xbrl.zip Edgar Link pending
a33123nref-exx311.htm Edgar Link pending
a33123nref-exx312.htm Edgar Link pending
a33123nref-exx321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nref-20230331.htm Edgar Link pending
nref-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
nref-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nref-20230331_pre.xml Edgar Link unprocessable
nref-20230331_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending